ANWENDUNG GEOPHYSIKALISCHER VERFAHREN BEI EINEM KRAFTWERKSPROJEKT AN DER OESTERREICHISCHEN = APPLICATION DES METHODES GEOPHYSIQUES POUR UN PROJET DE CENTRALE SUR LA PARTIE AUTRICHIENNE DU DANUBEGANGL G; MAKOVEC F; STEINHAUSER P et al.1980; ROCK MECH.; AUT; DA. 1980; VOL. 12; NO 3-4; PP. 193-219; ABS. ENG/FRE; BIBL. 2 P.Article

Discovery of new CCK₂ receptor antagonists. A review of pharmacological studies. Part I : Development of potential therapeutic tools for gastrin-related gastrointestinal diseasesREVEL, L; MAKOVEC, F.Methods and findings in experimental and clinical pharmacology. 1999, Vol 21, Num 5, pp 375-383, issn 0379-0355Article

Subsoil sealings of runoff-river stations on the Austria Danube = Ouvrages d'étanchéité du sous-sol des centrales hydro-électriques au fil de l'eau sur le Danube autrichienMAKOVEC, F; GRASSINGER, H.Congrès international des grands barrages. 15. 1985, Vol 15, Num 3, pp 733-748, issn 0254-0703Conference Paper

STUDIES ON THE MECHANISM OF ACTION OF PROTACINE (CR 604), A NEW, NON-STEROIDAL ANTI-INFLAMMATORY DRUGVIDAL Y PLANA RR; MAKOVEC F; CIFARELLI A et al.1979; ARZNEIMITTEL-FORSCH.; DEU; DA. 1979; VOL. 29; NO 8; PP. 1122-1125; ABS. GER; BIBL. 19 REF.Article

NEW 3-INDOLACETIC DERIVATIVES SHOWING A POTENT ANTI-INFLAMMATORY ACTIVITY AND SAFETY FOR GASTRIC MUCOSAMAKOVEC F; SENIN P; CASULA PL et al.1979; EUROP. J. MEDICIN. CHEM.; FRA; DA. 1979; VOL. 14; NO 5; PP. 447-454; ABS. FRE/GER; BIBL. 15 REF.Article

Detailuntersuchung der Diendorfer Störung bei Melk = Etude détaillée de la faille de Diendorf près de MelkSTEINHAUSER, P; GANGL, G; MAKOVEC, F et al.Tagungsbericht über das 2. Internationale Alpengravimetrie-Kolloquium Wien 1980. 1983, Num 11, pp 53-63Conference Paper

Novel potent and selective central 5-HT₃ receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT₃ receptorsCAPPELLI, A; ANZINI, M; BRUNI, G et al.Journal of medicinal chemistry (Print). 1999, Vol 42, Num 9, pp 1556-1575, issn 0022-2623Article

Characterization of antigastrin activity in vivo of CR 2194, a new R-4-benzamido-5-oxo-pentanoic acid derivativeREVEL, L; FERRARI, F; MAKOVEC, F et al.European journal of pharmacology. 1992, Vol 216, Num 2, pp 217-224, issn 0014-2999Article

CR 2039, a new bis-(1H-tetrazol-5-yl)phenylbenzamide derivative with potential for the optical treatment of asthmaREVEL, L; COLOMBO, S; FERRARI, F et al.European journal of pharmacology. 1992, Vol 229, Num 1, pp 45-53, issn 0014-2999Article

Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activityMAKOVEC, F; BANI, M; CHISTE, R et al.Arzneimittel-Forschung. 1986, Vol 36, Num 1, pp 98-102, issn 0004-4172Article

Determination of a novel angiotensin-AT₁ antagonist CR 3210 in biological samples by HPLCRIZZO, M; ANZINI, M; CAPPELLI, A et al.Il Farmaco (Pavia). 2003, Vol 58, Num 9, pp 837-844, issn 0014-827X, 8 p.Article

Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young malesPERSIANI, S; D'AMATO, M; MAKOVEC, F et al.International journal of clinical pharmacology and therapeutics. 2002, Vol 40, Num 5, pp 198-206, issn 0946-1965Article

CR 2249 : A new putative memory enhancer. Behavioural studies on learning and memory in rats and miceGAROFALO, P; COLOMBO, S; LANZA, M et al.Journal of pharmacy and pharmacology. 1996, Vol 48, Num 12, pp 1290-1297, issn 0022-3573Article

Antispasmodic activity of tiropramideSETNIKAR, I; CEREDA, R; PACINI, M. A et al.Arzneimittel-Forschung. 1989, Vol 39, Num 9, pp 1109-1114, issn 0004-4172Article

Identification of metabolites of tiropramide in human urineARIGONI, R; CHISTE, R; MAKOVEC, F et al.Biomedical & environmental mass spectrometry. 1988, Vol 15, Num 4, pp 205-209, issn 0887-6134Article

Pharmacokinetics of tiropramide after single doses in manARIGONI, R; CHISTE, R; DROVANTI, A et al.Arzneimittel-Forschung. 1986, Vol 36, Num 4, pp 738-744, issn 0004-4172Article

Protective effect of CR 1409 (cholecystokinin antagonist) on experimental pancreatitis in rats and miceMAKOVEC, F; BANI, M; CEREDA, R et al.Peptides (New York, NY. 1980). 1986, Vol 7, Num 6, pp 1159-1164, issn 0196-9781Article

Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjectsWEBBER, C; ROTH, A; CHASSEAUD, L. F et al.Xenobiotica (London. Print). 2003, Vol 33, Num 6, pp 625-641, issn 0049-8254, 17 p.Article

Pharmacokinetics of andolast after administration of single escalating doses by inhalation in mild asthmatic patientsPERSIANI, S; D'AMATO, M; MAKOVEC, F et al.Biopharmaceutics & drug disposition. 2001, Vol 22, Num 2, pp 73-81, issn 0142-2782Article

Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK_B receptor antagonistMAKOVEC, F; REVEL, L; LETARI, O et al.European journal of pharmacology. 1999, Vol 369, Num 1, pp 81-90, issn 0014-2999Article

Metabolism and excretion of ¹⁴C-tiropramide after single intravenous or peroral administration to the ratSETNIKAR, I; MAKOVEC, F; CHISTE, R et al.Arzneimittel-Forschung. 1989, Vol 39, Num 3, pp 328-334, issn 0004-4172Article

Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonistSETNIKAR, I; BANI, M; CEREDA, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 6, pp 703-707, issn 0004-4172Article

Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonistsMAKOVEC, F; BANI, M; CEREDA, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 11, pp 1265-1268, issn 0004-4172Article

Plasma levels of proglumetacin and its metabolites after intravenous or oral administration in the dogSETNIKAR, I; ARIGONI, R; CHISTE, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 6, pp 698-702, issn 0004-4172Article

Pharmacokinetic study of a new angiotensin-AT₁ antagonist by HPLCRIZZO, M; VENTRICE, D; CASALE, F et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 48, Num 2, pp 422-427, issn 0731-7085, 6 p.Conference Paper